Medication adherence in treating non-oncologic chronic pain: a problem to solve?
Emilie de Magalhães Pedreira, Viviane Borges Passos Mineiro, Luciana Maria Pondé Bastianelli Knop, Liliane Elze Falcão Lins-Kusterer, Durval Campos Kraychete
Abstract
Dear Editor,
The World Health Organization (WHO) understands adherence to be the behaviors of a patient regarding recommendations or treatment prescribed by healthcare professionals. Nonadherence to long-term treatment in the overall population is approximately 50%. This high rate encourages the investigation of elements involving nonadherence because it interferes with treatment results and prognosis.
Keywords
References
1. World Health Organization. Adherence to Long Ter Therapies Project. Evidence for Action. https://apps.who.int/iris/bitstream/handle/10665/42682/9241545992.pdf [Accessed 7 October 2020].
2. Drummond ED, Simoes TC, Andrade FB. An evaluation of non- ~ adherence to pharmacotherapy for chronic diseases and socioeconomic inequalities in Brazil. Rev Bras Epidemiol. 2020;23: e200080.
3. Llorca CVY, Cortes Castell E, Ribera Casado JM, de Lucas Ramos P, Casteig Ayestaran JL, Casteig Blanco A, et al. Factors associ- ated with non-adherence to drugs in patients with chronic diseases who go to pharmacies in Spain. Int J Environ Res Public Health. 2021;18:430.
4. Cowan R, Cohen J, Rosenman E, Iyer R. Physician and patient preferences for dosing options in migraine prevention. J Headache Pain. 2019;20:50.. 4.
5. Wong WS, Chow YF, Chen PP, Wong S, Fielding R. A longitudinal analysis on pain treatment satisfaction among Chinese patients with chronic pain: predictors and association with medical adherence, disability, and quality of life. Qual Life Res. 2015;24:2087.
6. Scherrer JF, Salas J, Grucza R, Sullivan MD, Lustman PJ, Copeland LA, et al. Depression and buprenorphine treatment in patients with non-cancer pain and prescription opioid dependence without comorbid substance use disorders. J Affect Disord. 2021;278:563−9.
7. Paterson C, Ledgerwood K, Arnold C, Hogg M, Xue C, Zheng Z. Resisting prescribed opioids: a qualitative study of decision making in patients taking opioids for chronic noncancer pain. Pain Med. 2016;17:717−27.
8. Sampaio R, Azevedo LF, Dias CC, Castro Lopes JM. Non-Adherence to pharmacotherapy: A prospective multicentre study about its incidence and its causes perceived by chronic pain patients. Patient Prefer Adherence. 2020;14:321−32.
9. Balsa A, García de Yebenes MJ, Carmona L. Multilevel factors predict medication adherence in rheumatoid arthritis: a 6- month cohort study. Ann Rheum Dis. 2022;81:327−34.
10. Lable SL, Cui Z, Shen W. Duloxetine treatment adherence across mental health and chronic pain conditions. Clinicoecon Outcomes Res. 2014;6:75−81.
11. Markotic F, Obrdalj E, Zalihic A, Pehar R, Hadziosmanovic Z, Pivic G, et al. Adherence to pharmacological treatment of chronic nonmalignant pain in individuals aged 65 and older. Pain Medicine. 2013;14:247−56.
Submitted date:
03/15/2023
Accepted date:
07/16/2023
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email